-
Product Insights
NewBacterial Vaginosis – Drugs In Development, 2024
Empower your strategies with our Bacterial Vaginosis – Drugs In Development, 2024 report and make more profitable business decisions. Bacterial vaginosis (BV), also known as vaginal bacteriosis, is a type of vaginal inflammation caused by the overgrowth of bacteria present in the vagina. Symptoms include vaginal itching, burning during urination, and watery and thin vaginal discharge. Treatment includes antibiotics. The Bacterial Vaginosis drugs in development market research report provide comprehensive information on the therapeutics under development for Bacterial Vaginosis, complete with...
-
Product Insights
NewIrritable Bowel Syndrome – Drugs In Development, 2024
Empower your strategies with our Irritable Bowel Syndrome – Drugs In Development, 2024 report and make more profitable business decisions. Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder that affects the large intestine (colon). Symptoms include cramping, abdominal pain, bloating gas, diarrhea, backache, muscle pains, poor appetite, and constipation. These symptoms can be triggered by food, stress, and hormones. Risk factors include age and family history. Treatment includes anti-diarrheal, anticholinergic, antidepressant, and antibiotic medications. The Irritable Bowel Syndrome drugs in...
-
Product Insights
NewUrinary Tract Infections – Drugs In Development, 2024
Empower your strategies with our Urinary Tract Infections – Drugs In Development, 2024 report and make more profitable business decisions. A urinary tract infection (UTI) is a bacterial infection that can occur in any part of the urinary system, including the kidneys, bladder, ureters, and urethra. Common symptoms include pain or burning during urination, frequent urination, urgency, lower abdominal discomfort, and cloudy or foul-smelling urine. UTIs are more common in women, and risk factors include factors such as sexual activity, urinary...
-
Product Insights
NewMajor Depressive Disorder – Drugs In Development, 2024
Empower your strategies with our Major Depressive Disorder – Drugs In Development, 2024 report and make more profitable business decisions. Major Depressive Disorder (MDD) is a common and severe mental health condition characterized by persistent feelings of sadness, hopelessness, and a lack of interest or pleasure in daily activities. Symptoms may include changes in appetite and sleep patterns, fatigue, difficulty concentrating, feelings of worthlessness, and thoughts of death or suicide. Diagnosis is based on the duration and intensity of these symptoms....
-
Sector Analysis
Healthy Snacks Market Size, Share, Trends and Analysis by Region, Products and Segment Forecast to 2030
Accessing the in-depth insights from the ‘Healthy Snacks’ report can help you: Make informed decisions about market entry, technology adoption, and project planning Identify your competitors' capabilities to stay ahead in the market Identify promising segments (products), growth trends, regional trends, and markets to expand your regional presence, product portfolio, and discover successful investment opportunities. Anticipate changes in demand and adjust your business development strategies. Identify ongoing potential projects across regions. How is our ‘Healthy Snacks’ report different from other reports in the market? The report...
-
Macroeconomic Analysis
Colombia PESTLE Insights – A Macroeconomic Outlook Report
Mining, manufacturing and utilities contributed 22.1% to gross value added (GVA) in 2022, followed by financial intermediation, real estate and business activities (21.9%) and wholesale, retail and hotels (13.7%), according to GlobalData. In nominal terms, the three sectors are forecast to grow by 6.2%, 7.8% and 6.6%, respectively, in 2023. Bogota, Cali and Medellin are among the best performing cities of Colombia. These areas contributed 33.2% of GDP and comprised 33.6% of Colombia’s population in 2022.
-
Sector Analysis
Plant-Based Food and Beverages Market Size, Share, Trends and Analysis by Region, Product, Source, Distribution and Segment Forecast to 2027
Plant-based Food & Beverages Market Report Overview The plant-based food & beverages market was valued at $94.2 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of more than 7% over the forecast period. Plant-based food and beverages encompass a variety of items made from natural plant-based ingredients such as vegetables, fruits, nuts, whole grains, legumes, and algae/fungi. These products are free from animal and animal-sourced ingredients such as milk, meat, or eggs. As...
-
Product Insights
Biostage Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Biostage Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Biostage Inc (Biostage) operates as a biotechnology company. The company carries out the business of development and commercialization of regenerated organs for human transplant. It develops bioengineered organ implants based on the its Cellframe technology which combines biocompatible scaffold with a patient's own stem cells to create Cellspan organ implants. Biostage’s pipeline offerings include Cellspan bronchial implants, Cellspan esophageal implants...
-
Sector Analysis
Eastern European Dairy and Soy Food Market Size, Competitive Landscape, Country Analysis, Distribution Channel, Packaging Formats and Forecast, 2021-2026
The global dairy & soy food sector was valued at $650.5 billion in 2021 and is expected to yield a CAGR of 9.2% during 2021-26, to reach $1 trillion in 2026. Eastern Europe registered value sales of $55.5 billion in 2021 and is expected to register value CAGR of 10.9% during 2021-26. In volume terms, meanwhile, the region emerged as the second-smallest market with 20.3 billion kg in sales. Over the forecast period, its dairy & soy food sector is...